Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

Share

Karo Pharma AS

Closing information (x1000 DKK)

Closing information 2024/12 2023/12 2022/12
Turnover 449,793 More Arrow 458,845 Less Arrow 452,630
Financial expenses 2,853 More Arrow 10,737 Less Arrow 6,538
Earnings before taxes 118,085 Less Arrow 107,032 Less Arrow 89,154
Total assets 316,279 Less Arrow 298,077 Less Arrow 269,199
Current assets 293,213 Less Arrow 272,421 Less Arrow 239,024
Current liabilities 188,575 More Arrow 197,934 Less Arrow 164,442
Equity capital 127,704 Less Arrow 100,143 More Arrow 104,756
- share capital 4,281 More Arrow 4,507 More Arrow 4,802

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 40.4% Less Arrow 33.6% More Arrow 38.9%
Turnover per employee
Profit as a percentage of turnover 26.3% Less Arrow 23.3% Less Arrow 19.7%
Return on assets (ROA) 38.2% More Arrow 39.5% Less Arrow 35.5%
Current ratio 155.5% Less Arrow 137.6% More Arrow 145.4%
Return on equity (ROE) 92.5% More Arrow 106.9% Less Arrow 85.1%
Change turnover 13,982 More Arrow 34,028 More Arrow 96,403
Change turnover % 3% More Arrow 8% More Arrow 27%
Chg. No. of employees
Chg. No. of employees %

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.